1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA YIF1A CTRPv2 pan-cancer AAC -0.16 3e-06
mRNA DBR1 CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA MTA2 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA BCAR3 CTRPv2 pan-cancer AAC -0.17 3e-06
mRNA PRPF39 CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA PHLDA1 CTRPv2 pan-cancer AAC -0.17 3e-06
mRNA ARID2 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA SV2A CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA PTOV1 CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA CTXN1 CTRPv2 pan-cancer AAC 0.16 3e-06
Download CSV